The FDA is reevaluating the safety of children's cold medicines, especially for those under 2 years old.
Pediatricians and health officials are urging a ban on marketing these remedies to children under 6 due to concerns about overdoses.
Recent studies have shown serious health issues and deaths in young children after taking common cold medicines.
Johnson & Johnson voluntarily recalled certain infant cough and cold products to prevent misuse and overdoses.
The FDA is reviewing the safety and effectiveness of these medications, with a focus on children under 2.
Manufacturers are withdrawing infant cough and cold medicines from the market due to safety concerns.
